TNFα inhibitors reduce bone loss in rheumatoid arthritis independent of clinical response by reducing osteoclast precursors and IL-20

TNFα inhibitors reduce bone loss in rheumatoid arthritis independent of clinical response by reducing osteoclast precursors and IL-20

<p><strong>Objectives</strong></p> <p>About half of RA patients treated with TNFα inhibitors either do not respond or lose their initial therapeutic response over time. The clinical response is measured by reduction in DAS28, which primarily reflects inflammation. Howev...

Bibliografske podrobnosti
Main Authors:	Al-Bogami, M, Bystrom, J, Clanchy, F, Taher, TE, Mangat, P, Williams, RO, Jawad, AS, Mageed, RA
Format:	Journal article
Jezik:	English
Izdano:	Oxford University Press 2020

Podobne knjige/članki

Response to treatment with TNFα inhibitors in rheumatoid arthritis is associated with high levels of GM-CSF and GM-CSF(+) T lymphocytes
od: Bystrom, J, et al.
Izdano: (2017)

TNFα in the regulation of Treg and Th17 cells in rheumatoid arthritis and other autoimmune inflammatory diseases
od: Bystrom, J, et al.
Izdano: (2016)

Disease status in human and experimental arthritis, and response to TNF blockade, is associated with MHC class II invariant chain (CD74) isoform expression
od: Clanchy, FIL, et al.
Izdano: (2022)

TLR expression profiles are a function of disease status in rheumatoid arthritis and experimental arthritis
od: Clanchy, FIL, et al.
Izdano: (2021)

Inflammatory disease status and response to TNF blockade are associated with mechanisms of endotoxin tolerance
od: Taylor, PC, et al.
Izdano: (2024)

New insights into inflammatory osteoclast precursors as therapeutic targets for rheumatoid arthritis and periodontitis
od: Emilie Hascoët, et al.
Izdano: (2023-05-01)

Osteoclasts and their circulating precursors in rheumatoid arthritis: Relationships with disease activity and bone erosions
od: H. Allard-Chamard, et al.
Izdano: (2020-06-01)

Harnessing the Therapeutic Potential of Th17 Cells.
od: Bystrom, J, et al.
Izdano: (2015)

Osteoclast differentiation in rheumatoid arthritis
od: Kazuhiro Yokota
Izdano: (2024-01-01)

Methotrexate Reduced TNF Bioactivity in Rheumatoid Arthritis Patients Treated with Infliximab
od: Delphine Dénarié, et al.
Izdano: (2017-01-01)

Functional and phenotypic heterogeneity of Th17 cells in health and disease
od: Bystrom, J, et al.
Izdano: (2018)

Pathological Osteoclasts and Precursor Macrophages in Inflammatory Arthritis
od: Tetsuo Hasegawa, et al.
Izdano: (2022-04-01)

Lymphocytes: precursor frequencies
od: Clanchy, F, et al.
Izdano: (2017)

Anti-TNF therapy reduces serum levels of chemerin in rheumatoid arthritis: a new mechanism by which anti-TNF might reduce inflammation.
od: Marieke M J Herenius, et al.
Izdano: (2013-01-01)

Regulation of differentiation and generation of osteoclasts in rheumatoid arthritis
od: Qing Niu, et al.
Izdano: (2022-11-01)

Harnessing the Therapeutic Potential of Th17 Cells
od: Jonas Bystrom, et al.
Izdano: (2015-01-01)

Osteoclast formation and activity in the pathogenesis of osteoporosis in rheumatoid arthritis.
od: Hirayama, T, et al.
Izdano: (2002)

The role of osteoclast formation in the pathogenesis of osteoporosis in rheumatoid arthritis
od: Hirayama, T, et al.
Izdano: (2001)

The monocyte-to-osteoclast transition in rheumatoid arthritis: Recent findings
od: Naoki Iwamoto, et al.
Izdano: (2022-09-01)

CD14+CD16− monocytes are the main precursors of osteoclasts in rheumatoid arthritis via expressing Tyro3TK
od: Jimeng Xue, et al.
Izdano: (2020-09-01)

20th anniversary of TNF inhibitors in rheumatoid arthritis
od: Taylor, P
Izdano: (2019)

ANTI TNF THERAPY IN RHEUMATOID ARTHRITIS
od: Feldmann, M, et al.
Izdano: (2011)

Adipokines in psoriatic arthritis patients: the correlations with osteoclast precursors and bone erosions.
od: Yu Xue, et al.
Izdano: (2012-01-01)

Cellular mechanisms of osteoclast formation and bone resorption in rheumatoid arthritis
od: Danks, L, et al.
Izdano: (2001)

TNF-alpha in rheumatoid arthritis and prospects of anti-TNF therapy.
od: Maini, R, et al.
Izdano: (1993)

Th17 Lymphocytes in Respiratory Syncytial Virus Infection
od: Rizgar A. Mageed, et al.
Izdano: (2013-03-01)

Mir-342-3p regulates ostoclastogenesis in arthritis-associated osteoclast precursors
od: Claire Lozano, et al.
Izdano: (2020-10-01)

Development of anti-TNF therapy for rheumatoid arthritis.
od: Feldmann, M
Izdano: (2002)

Targeting TNF alpha for the therapy of rheumatoid arthritis.
od: Maini, R, et al.
Izdano: (1994)

Preventive CCL2/CCR2 Axis Blockade Suppresses Osteoclast Activity in a Mouse Model of Rheumatoid Arthritis by Reducing Homing of CCR2hi Osteoclast Progenitors to the Affected Bone
od: Darja Flegar, et al.
Izdano: (2021-12-01)

The role of light in osteoclast formation and pathological bone resorption in rheumatoid arthritis
od: Athanasou, NA, et al.
Izdano: (2017)

Rheumatoid arthritis synovial macrophage-osteoclast differentiation is osteoprotegerin ligand-dependent.
od: Itonaga, I, et al.
Izdano: (2000)

Osteoclast microRNA Profiling in Rheumatoid Arthritis to Capture the Erosive Factor
od: Nguyen Hoang Dong, et al.
Izdano: (2023-08-01)

How Autoantibodies Regulate Osteoclast Induced Bone Loss in Rheumatoid Arthritis
od: Ulrike Steffen, et al.
Izdano: (2019-07-01)

The number of CD14+osteoclast precursors in acute charcot patients is correlated to the serum levels of tnf-alpha
od: Mabilleau, G, et al.
Izdano: (2009)

Regulation of TNF-Induced Osteoclast Differentiation
od: Zhenqiang Yao, et al.
Izdano: (2021-12-01)

TNF, SOLUBLE RECEPTORS AND AUTOANTIBODIES TO TNF OF PATIENTS WITH RHEUMATOID ARTHRITIS AND HEALTHY DONORS
od: E. A. Golikova, et al.
Izdano: (2012-05-01)

Adalimumab reduces hand bone loss in rheumatoid arthritis independent of clinical response: Subanalysis of the PREMIER study
od: Elden Aake, et al.
Izdano: (2011-02-01)

Abatacept reduces disease activity of rheumatoid arthritis independently of modulating anti-citrullinated peptide antibody production
od: Hisakata Yamada, et al.
Izdano: (2020-04-01)

Reduced skeletal muscle independently predicts 1-year aggravated joint destruction in patients with rheumatoid arthritis
od: Jian-Zi Lin, et al.
Izdano: (2020-08-01)